NIH-funded research NIH-funded research

How obesity affects the heart in HFpEF

Official title: Intersection of Obesity and Heart Failure with Preserved Ejection Fraction

Funded at Johns Hopkins University · NIH-11253294 · Data updated 2026-11-12

Researchers will study how obesity changes heart muscle in people with heart failure with preserved ejection fraction to help develop more tailored treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 20, 2023
Project endDecember 31, 2029
Funding year2026
Award (this year)$1,089,224
NIH project number5R35HL166565-04
Project IDNIH-11253294 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults diagnosed with HFpEF, particularly those who are obese or have diabetes/metabolic syndrome, and who can attend clinic visits and possibly provide tissue samples.

Less likely to help

People without HFpEF or those unwilling/unable to undergo invasive testing such as myocardial biopsy are unlikely to directly benefit from participation.

What this research studies

You would join work led at Johns Hopkins that focuses on people with HFpEF, many of whom are obese, female, and African American, to understand how obesity and metabolic problems change the heart. The team collects detailed clinical information and obtains heart tissue biopsies along with metabolic and molecular testing to look for specific cellular and metabolic changes. Comparing patient subgroups helps pinpoint biological pathways linked to worse symptoms and outcomes. The goal is to identify precise targets that could guide new treatments and to validate findings using laboratory models.

Why it matters

Potential benefit: If successful, the project could lead to more effective, personalized treatments for obese patients with HFpEF that reduce symptoms and improve outcomes.

How similar studies have gone: Earlier studies have suggested metabolic and fibrotic changes in HFpEF but this program's detailed tissue-based approach is relatively novel and more comprehensive.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Kass, David Alan — Johns Hopkins University
  • Study coordinator: Kass, David Alan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.